Bunamiodyl Chemische Eigenschaften,Einsatz,Produktion Methoden

Trademarks

Bunaiod;Orabilex;Orabilix.

Weltgesundheitsorganisation (WHO)

Bunamiodyl, an orally administered radio-opaque medium, was introduced in 1958 for use in the examination of the biliary tract. By 1964 its use had been associated with cases of renal failure, in some cases fatal, which resulted in its withdrawal by the United States Food and Drug Administration. Buniamiodyl was withdrawn worldwide by the manufacturer in 1984.

Bunamiodyl Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Bunamiodyl Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Shaanxi Xihua Chemical Industry Co., Ltd	029-89586681 15829046862	1020@dideu.com	China	9433	58

---

• Bunamiodyl
• buniodyl
• 2-[[2,4,6-Triiodo-3-[(1-oxobutyl)amino]phenyl]methylene]butanoic acid
• 1923-76-8 (Hydrochloride salt)
• 2-(3-Butyramido-3,4,6-triiodophenylmethylene)butyric acid
• 3-(3-Butylamido-2,4,6-triiodphenyl)-2-ethylacrylsaeure
• Bunamijodylum
• Bunamiodilo
• Bunamiodilo [inn-spanish]
• Bunamiodyl [inn:ban]
• Bunamiodylum
• Butanoic acid, 2-[[2,4,6-triiodo-3-[(1-oxobutyl)amino]phenyl]methylene]-
• 1233-53-0